Chapter 15. Anaphylaxis

  1. Brian H. Rowe MD, MSc, CCFP(EM), FCCP Professor Research Director
  1. Theodore Gaeta DO, MPH Vice-Chairman Residency Director Associate Professor of Emergency in Clinical Medicine1,2

Published Online: 27 FEB 2009

DOI: 10.1002/9781444303674.ch15

Evidence-Based Emergency Medicine

Evidence-Based Emergency Medicine

How to Cite

Gaeta, T. (2008) Anaphylaxis, in Evidence-Based Emergency Medicine (ed B. H. Rowe), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444303674.ch15

Editor Information

  1. Department of Emergency Medicine, University of Alberta, Edmonton, Alberta, Canada

Author Information

  1. 1

    Department of Emergency Medicine, New York Methodist Hospital, Brooklyn, New York, USA

  2. 2

    Weill Medical College of Cornell University, New York, USA

Publication History

  1. Published Online: 27 FEB 2009
  2. Published Print: 31 OCT 2008

ISBN Information

Print ISBN: 9781405161435

Online ISBN: 9781444303674



  • anaphylaxis;
  • epinephrine - treatment of choice and anaphylaxis drug therapy;
  • histamine in acute allergic inflammation during anaphylaxis;
  • MEDLINE and EMBASE: (anaphylaxis OR allergic reaction) AND (steroids OR corticosteroids);
  • corticosteroids effectiveness in anaphylaxis;
  • International Classification of Disease (ICD) codes;
  • MEDLINE and EMBASE: (anaphylaxis OR allergic reaction) AND (adrenaline OR epinephrine) AND self-injectable;
  • treatment protocols - evidence based and validated by high-quality clinical studies


This chapter contains sections titled:

  • Case scenario

  • Background

  • Clinical questions

  • General search strategy

  • Critical review of the literature

  • Conclusions

  • Acknowledgments

  • Conflicts of interest

  • References